Stefan Jenni1, Marcel Adler2, Simone Lanz1, Behrouz Mansouri Taleghani2, Emanuel R Christ1. 1. Department of Endocrinology, Diabetology and Clinical Nutrition, Bern University Hospital, Inselspital, Bern, Switzerland. 2. University Clinic of Haematology and Central Haematology Laboratory, Bern University Hospital, Inselspital, Bern, Switzerland.
Abstract
BACKGROUND: Pharmacodynamic studies and data concerning adaptation of thyroid substitution in patients with substituted hypothyroidism during plasma exchange (PE) is not available. CASE REPORT: We measured TSH, fT3 and fT4, total T4, thyroxin binding globulin (TBG), and albumin before and after 5 PE procedures in a 37-year-old women who underwent PE for a therapy-resistant polyneuropathy. Thyroxin was increased empirically by 8% resulting in a dose of 1.95 µg/kg per day. RESULTS: Despite larger reductions of total T4 and TBG over a series of 5 PEs (40-50% from baseline), only small reductions of 8% in fT3 and fT4 concentrations were documented with a concomittant increase in TSH level. Changes of fT4, fT3, and TSH remained within normal range. CONCLUSIONS: i) Despite a significant decrease in total thyroid hormone pool following PE, fT4, fT3, and TSH concentrations changed only slightly. ii) Based on this observation, a general increase in thyroid replacement therapy before PE cannot be recommended, but considered in case of a high normal TSH level.
BACKGROUND: Pharmacodynamic studies and data concerning adaptation of thyroid substitution in patients with substituted hypothyroidism during plasma exchange (PE) is not available. CASE REPORT: We measured TSH, fT3 and fT4, total T4, thyroxin binding globulin (TBG), and albumin before and after 5 PE procedures in a 37-year-old women who underwent PE for a therapy-resistant polyneuropathy. Thyroxin was increased empirically by 8% resulting in a dose of 1.95 µg/kg per day. RESULTS: Despite larger reductions of total T4 and TBG over a series of 5 PEs (40-50% from baseline), only small reductions of 8% in fT3 and fT4 concentrations were documented with a concomittant increase in TSH level. Changes of fT4, fT3, and TSH remained within normal range. CONCLUSIONS: i) Despite a significant decrease in total thyroid hormone pool following PE, fT4, fT3, and TSH concentrations changed only slightly. ii) Based on this observation, a general increase in thyroid replacement therapy before PE cannot be recommended, but considered in case of a high normal TSH level.
Authors: Joseph Schwartz; Jeffrey L Winters; Anand Padmanabhan; Rasheed A Balogun; Meghan Delaney; Michael L Linenberger; Zbigniew M Szczepiorkowski; Mark E Williams; Yanyun Wu; Beth H Shaz Journal: J Clin Apher Date: 2013-07 Impact factor: 2.821
Authors: Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman Journal: J Clin Endocrinol Metab Date: 2002-02 Impact factor: 5.958
Authors: J Binimelis; L Bassas; L Marruecos; J Rodriguez; M L Domingo; P Madoz; S Armengol; M A Mangues; A de Leiva Journal: Intensive Care Med Date: 1987 Impact factor: 17.440
Authors: B Stegmayr; J Ptak; B Wikström; G Berlin; C G Axelsson; A Griskevicius; P Centoni; G Liumbruno; P Molfettini; J Audzijoniene; K Mokvist; B Nilsson Sojka; R Norda; F Knutson; W Ramlow; M Blaha; V Witt; M Evergren; J Tomaz Journal: Transfus Apher Sci Date: 2008-10-31 Impact factor: 1.764